AR-V7 and prostate cancer: The watershed for treatment selection?

Cancer Treatment Reviews
Chiara CiccareseFrancesco Massari

Abstract

The androgen receptor (AR) plays a key role in progression to metastatic castration-resistant prostate cancer (mCRPC). Despite the recent progress in targeting persistent AR activity with the next-generation hormonal therapies (abiraterone acetate and enzalutamide), resistance to these agents limits therapeutic efficacy for many patients. Several explanations for response and/or resistance to abiraterone acetate and enzalutamide are emerging, but growing interest is focusing on importance of AR splice variants (AR-Vs) and in particular of AR-V7. Increasing evidences highlight the concept that variant expression could be used as a potential predictive biomarker and a therapeutic target in advanced prostate cancer. Therefore, understanding the mechanisms of treatment resistance or sensitivity can help to achieve a more effective management of mCRPC, increasing clinical outcomes and representing a promising and engaging area of prostate cancer research.

References

May 25, 1995·The New England Journal of Medicine·M E TaplinS P Balk
Dec 10, 1999·The New England Journal of Medicine·M A Eisenberger, P C Walsh
Sep 30, 2000·Urological Research·Z CuligH Klocker
Apr 5, 2002·Molecular Cell·Yongfeng ShangMyles Brown
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward P Gelmann
Sep 19, 2002·Endocrine-related Cancer·Z CuligA Hobisch
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Jocelyn CéralineJean-Pierre Bergerat
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark A TitusJames L Mohler
Mar 7, 2006·Journal of Cellular Biochemistry·Scott M Dehm, Donald J Tindall
Jul 25, 2006·Nature Reviews. Cancer·Levi A Garraway, William R Sellers
Jul 21, 2010·The Journal of Clinical Investigation·Shihua SunStephen R Plymate
Sep 3, 2010·Cancer Research·Meng-Lei ZhuNatasha Kyprianou
Sep 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Philip A WatsonCharles L Sawyers
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Jul 23, 2011·Endocrine-related Cancer·Scott M Dehm, Donald J Tindall
Jul 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Kai-Hsiung ChangNima Sharifi
Aug 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elahe A MostaghelR Bruce Montgomery
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Apr 2, 2013·European Urology·Giuseppe Di Lorenzo, Carlo Buonerba
May 24, 2013·Molecular Cancer Therapeutics·Nagalakshmi NadimintyAllen C Gao
Jun 1, 2013·The Journal of Clinical Investigation·Jae-Kyung MyungMarianne D Sadar

❮ Previous
Next ❯

Citations

Jun 2, 2016·Der Urologe. Ausg. A·G Theil, P Fornara
May 24, 2016·Expert Review of Anticancer Therapy·Chiara CiccareseFrancesco Massari
Sep 18, 2016·Critical Reviews in Oncology/hematology·Giulia Baciarello, Cora N Sternberg
Jun 19, 2017·Molecular and Cellular Endocrinology·Alfonso Urbanucci, Ian G Mills
Jan 11, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joo Hyoung LeeSelvarangan Ponnazhagan
Feb 29, 2020·International Journal of Molecular Sciences·Toshihiko TakeiwaSatoshi Inoue
Sep 18, 2018·International Journal of Oncology·Zhi-Guang HuangZeng-Nan Mo
Jan 29, 2020·Expert Review of Molecular Diagnostics·Roberto IacovelliGiampaolo Tortora
Feb 26, 2020·Prostate Cancer and Prostatic Diseases·Landon C BrownAndrew J Armstrong
Sep 12, 2020·Cells·Alessandro RizzoFrancesco Massari
May 6, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jieping HuTing Sun
Oct 20, 2020·Frontiers in Oncology·Giorgia GurioliUgo De Giorgi
Dec 2, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chao WangYing-Hao Sun
Aug 5, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fangfang QuPhilip W Kantoff
Dec 15, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ke LuYongchang Chen
Feb 10, 2021·International Journal of Molecular Sciences·Matteo RoselliniFrancesco Massari
Feb 28, 2017·Asian Journal of Urology·Jin Xu, Yun Qiu
May 26, 2021·Medical Oncology·Milap H DesaiRashmika R Potdar
Jul 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V CappellettiL D Locati
Jul 25, 2021·Cancers·Alessia CimadamoreRodolfo Montironi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.